Capital CS Group, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital CS Group, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$146,509
-66.3%
17,5250.0%0.17%
-60.0%
Q2 2023$435,321
+65.2%
17,5250.0%0.43%
+73.9%
Q1 2023$263,576
+27.1%
17,5250.0%0.25%
+8.7%
Q4 2022$207,321
+99.3%
17,5250.0%0.23%
+104.5%
Q3 2022$104,000
+40.5%
17,5250.0%0.11%
+45.5%
Q2 2022$74,000
-55.7%
17,5250.0%0.08%
-46.9%
Q1 2022$167,000
-60.5%
17,525
-21.1%
0.14%
-56.3%
Q4 2021$423,000
-34.7%
22,2250.0%0.33%
-44.8%
Q3 2021$648,00022,2250.60%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders